Caspar da Cunha‐Bang

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

Barbara Eichhorst, Carsten Utoft Niemann, Arnon P. Kater et al. · New England Journal of Medicine · 2023 · 268 citations · Full text

Improved survival for patients diagnosed with chronic lymphocytic leukemia in the era of chemo-immunotherapy: a Danish population-based study of 10455 patients

Caspar da Cunha‐Bang, Jacob Simonsen, Klaus Rostgaard et al. · Blood Cancer Journal · 2016 · 72 citations · Full text

Patients with CLL have a lower risk of death from COVID-19 in the Omicron era

Carsten Utoft Niemann, Caspar da Cunha‐Bang, Marie Helleberg et al. · Blood · 2022 · 67 citations · Full text

First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial

Moritz Fürstenau, Arnon P. Kater, Sandra Robrecht et al. · The Lancet Oncology · 2024 · 59 citations · Full text

Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death

Emelie Curovic Rotbain, Carsten Utoft Niemann, Klaus Rostgaard et al. · Leukemia · 2021 · 51 citations · Full text

Individual Comorbidities, Lymphoid Neoplasia, Hematological Malignancy +9